Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Rapport Therapeutics, Inc. (RAPP)

NASDAQ

$42.70

$--

(0.00%)

Pre-Market

Rapport Therapeutics, Inc. (RAPP) Live Price Chart

Last updated: ⁦2026-09-16 13:20:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Rapport Therapeutics, Inc. (RAPP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $42.70, with a market capitalisation of $2.11B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $23.75 to $52.93. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.11B
Open	$42.70
Day's High	$52.93
Day's Low	$6.43
Previous Close	$42.68
Volume	212.00
Average Volume	347.56K
P/E Ratio	--
52-Week High	$52.93
52-Week Low	$23.75
Dividend Yield	--
Earnings Date	--

Rapport Therapeutics, Inc. (RAPP) Pre-Market Stock Price

Rapport Therapeutics, Inc. (RAPP) is trading at $42.70 in pre-market trading as of 2026-09-16 11:10:00, up 0.04% ($0.02) from the previous close of $42.68

Pre-market trading shows how investors are pricing RAPP before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Rapport Therapeutics, Inc. (RAPP) 7-Day Stock Price Change

Over the past seven days, Rapport Therapeutics, Inc. (RAPP) moved from $45.77 to $42.70, representing a decline of 6.72% ($3.08).

The stock traded between $41.76 and $48.00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 309.19 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

RAPP 52-Week Price Position

Position in Range: 64.9%

52W Low$23.75

52W High$52.93

RAPP is currently trading at $42.70, placing it 64.9% of the way from its 52-week low of $23.75 to its 52-week high of $52.93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Rapport Therapeutics, Inc. (RAPP)?

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.

Rapport Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	84
Exchange	NASDAQ
Company Website	https://www.rapportrx.com

How to Buy Rapport Therapeutics, Inc. (RAPP) Stock on MEXC

Eligible investors can buy real shares of Rapport Therapeutics, Inc. (RAPP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RAPP and Place Your Order

Open the RealStocks trading page and search for RAPP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Rapport Therapeutics, Inc. (RAPP) stock price today?

Rapport Therapeutics, Inc. (RAPP) is currently trading at $ 42.70, up 0.04% ($0.02) from the previous close of $ 42.68. Intraday prices update in real time during regular trading hours.

2.Is RAPP stock going up or down today?

As of 2026-09-16 11:10:00, RAPP is trading at $ 42.70, up 0.04% ($0.02) from its previous close of $ 42.68. The stock has traded between $ 6.43 and $ 52.93 during today’s regular session. Past price movements do not guarantee future results.

3.What is RAPP pre-market price?

As of 2026-09-16 11:10:00, RAPP is trading at $ 42.70 in pre-market trading, up 0.04% ($0.02) from the previous close of $ 42.68. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RAPP after-hours price?

As of 2026-09-16 11:10:00, RAPP is trading at $ 42.70 in after-hours trading, up 0.04% ($0.02) from the regular-session close of $ 42.68. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RAPP stock trading now?

RAPP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RAPP sit relative to its 52-week high and low?

Over the past 52 weeks, RAPP has traded between a low of $ 23.75 and a high of $ 52.93. At $ 42.70, the stock is positioned 64.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Rapport Therapeutics, Inc. in?

Rapport Therapeutics, Inc. (RAPP) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Rapport Therapeutics, Inc.'s market capitalisation and where is it listed?

Rapport Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 2.11B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RAPP valued in terms of P/E ratio and EPS?

RAPP trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.86. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Rapport Therapeutics, Inc. pay a dividend?

Rapport Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.